# Iron Therapy in Patients With End-Stage Renal Disease

> **NCT04491916** · NA · UNKNOWN · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- End-stage Renal Disease
- Anemia
- Cardiovascular Risk Factor
- Inflammation

## Interventions

- **DRUG:** irone sucrose

## Key facts

- **NCT ID:** NCT04491916
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491916, "Iron Therapy in Patients With End-Stage Renal Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04491916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*